BAIAP2L2 promotes the malignancy of hepatocellular carcinoma via GABPB1-mediated reactive oxygen species imbalance
Wenbo Jia, Bin Xu, Liang Yu, Yanzhi Feng, Jinyi Wang, Chao Xu, Litao Liang, Yongping Zhou, Wenzhou Ding, Lianbao Kong · 2024
Read BAIAP2L2 promotes the malignancy of hepatocellular carcinoma via GABPB1-mediated reactive oxygen species imbalance by Wenbo Jia, Bin Xu, Liang Yu, Yanzhi Feng, Jinyi Wang, Chao Xu, Litao Liang, Yongping Zhou, Wenzhou Ding, Lianbao Kong (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11645275.txt.
Description
Wenbo Jia and co-authors trace, in a 2024 study, how a little-known protein helps liver cancer grow and shrug off treatment. The protein, called BAIAP2L2, runs high in tumor tissue, and patients with more of it fare worse. In lab tests it pushed cancer cells to multiply, spread, take on stem-like traits, and dodge cell death, while a stress switch in the cell switched the protein's own gene on.
The mechanism runs through a partner protein. The cancer protein grabs it, shields it from disposal, and escorts it into the nucleus. From there, the pair keeps reactive oxygen levels low, which feeds the tumor's growth and blunts a standard liver cancer drug. The authors name the protein a candidate marker for prognosis and a possible drug target. Blocking it, they suggest, might restore the drug's bite.
Catalog record
| CREATOR | Wenbo Jia, Bin Xu, Liang Yu, Yanzhi Feng, Jinyi Wang, Chao Xu, Litao Liang, Yongping Zhou, Wenzhou Ding, Lianbao Kong |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 63 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |